Absci (ABSI) Revenue (2020 - 2026)

Absci (ABSI) reported Revenue of $215000.0 for Q1 2026, down 81.76% on a YoY basis from $1.2 million in Q1 2025, and down 66.92% sequentially from $650000.0 in Q4 2025.

Absci (ABSI) Revenue (2020 - 2026) Analysis & Trends

Absci (ABSI) has 7 years of Revenue data on file, last reported at $215000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Revenue fell 81.76% year-over-year to $215000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (down 61.87% YoY), and the FY2025 full-year result was $2.8 million, down 38.24% from the prior year.
  • Revenue fell to $215000.0 in Q1 2026, from $650000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.4 million in Q2 2023 to a low of $215000.0 in Q1 2026.
  • A 5-year average of $902235.3 and a median of $665000.0 in 2024 frame the typical range for Revenue.
  • Across the five-year window, Revenue jumped 247.67% in 2023 and sank 81.76% in 2026, its largest moves.
  • Tracing ABSI's Revenue over 5 years: stood at $339000.0 in 2022, then decreased by 0.29% to $338000.0 in 2023, then soared by 96.75% to $665000.0 in 2024, then declined by 2.26% to $650000.0 in 2025, then slumped by 66.92% to $215000.0 in 2026.
  • Business Quant data shows ABSI's Revenue at $215000.0 in Q1 2026, $650000.0 in Q4 2025, and $378000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1.30 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Absci 1.16 Bn 1.03 Bn - 215,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 215,000.00
Dec 31, 2025 650,000.00
Sep 30, 2025 378,000.00
Jun 30, 2025 593,000.00
Mar 31, 2025 1.18 Mn
Dec 31, 2024 665,000.00
Sep 30, 2024 1.70 Mn
Jun 30, 2024 1.27 Mn
Mar 31, 2024 898,000.00
Dec 31, 2023 338,000.00
Sep 30, 2023 744,000.00
Jun 30, 2023 3.37 Mn
Mar 31, 2023 1.27 Mn
Dec 31, 2022 339,000.00
Sep 30, 2022 365,000.00
Jun 30, 2022 1.00 Mn
Mar 31, 2022 365,000.00
Dec 31, 2021 -2.15 Mn
Sep 30, 2021 149,000.00
Jun 30, 2021 728,000.00